We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
National Institute For Occupational Safety And Health Partners With Protea
News

National Institute For Occupational Safety And Health Partners With Protea

National Institute For Occupational Safety And Health Partners With Protea
News

National Institute For Occupational Safety And Health Partners With Protea

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "National Institute For Occupational Safety And Health Partners With Protea"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Protea Biosciences Group, Inc. has announced that the National Institute for Occupational Safety and Health (NIOSH) has established a scientific collaboration with Protea’s Imaging and Bioanalytical Laboratory to study the occupational hazards of the inhalation of aerosols released during welding and electronic manufacturing processes. NIOSH is the federal agency that conducts research and makes recommendations for preventing work-related injuries, illnesses, and deaths. 

“During welding, workers are exposed to fumes that may contain potentially harmful chemicals like manganese, chromium, and nickel,” stated James Antonini, PhD., Toxicologist in the Health Effects Laboratory Division of NIOSH in Morgantown, WV. He continued, “Previous research suggests that these workers who are exposed to these fumes may be at a higher risk for lung disease, neurological disorders, and infection, and we are working with Protea’s Imaging and Bioanalytical Laboratory to understand the molecular interaction and physiological impact of these inhalants using mass spectrometry imaging.”

“Our core focus is to provide expertise and state-of-the-art mass spectrometry imaging tools to researchers interested in visualizing chemicals and biomolecules within tissue samples,” stated Greg Kilby, Ph.D., Protea’s Vice President of Operations. He continued, “Developing and applying mass spectrometry imaging workflows for these inhalation studies enables us to deliver molecular images and analytical results, which ultimately have an impact on workplace safety for millions of workers within these industries.” The results of this collaboration are planned to be presented by investigators from both NIOSH and Protea at the 54th Society of Toxicology Annual Meeting on March 22-26th in San Diego.

Advertisement